Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 GBX | +7.69% | -19.54% | -56.92% |
08:00am | Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Mar. 15 | Genedrive down as plans equity raise despite GBP800,000 tax credit | AN |
Sales 2022 | 49K 61.82K | Sales 2023 | 55K 69.39K | Capitalization | 17.33M 21.87M |
---|---|---|---|---|---|
Net income 2022 | -4M -5.05M | Net income 2023 | -5M -6.31M | EV / Sales 2022 | 237 x |
Net cash position 2022 | 4.57M 5.77M | Net cash position 2023 | 2.36M 2.98M | EV / Sales 2023 | 272 x |
P/E ratio 2022 |
-3.18
x | P/E ratio 2023 |
-3.18
x | Employees | 43 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.62% |
1 day | -2.92% | ||
1 week | -27.47% | ||
Current month | -36.90% | ||
1 month | -33.58% | ||
3 months | -61.17% | ||
6 months | -71.96% | ||
Current year | -61.17% |
Managers | Title | Age | Since |
---|---|---|---|
James Cheek
CEO | Chief Executive Officer | 57 | 23-09-10 |
Russell Shaw
DFI | Director of Finance/CFO | 45 | 22-04-06 |
Ian Gilham
CHM | Chairman | 64 | 14-11-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Gilham
CHM | Chairman | 64 | 14-11-23 |
Chris Yates
BRD | Director/Board Member | 50 | 18-08-21 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 18-04-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.5 | +7.69% | 2 007 574 |
24-03-27 | 3.25 | +4.00% | 1,363,017 |
24-03-26 | 3.125 | -10.71% | 2,879,762 |
24-03-25 | 3.5 | -6.67% | 1,017,144 |
24-03-22 | 3.75 | -13.79% | 3,324,652 |
Delayed Quote London S.E., March 28, 2024 at 06:54 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.17% | 5.68M | |
+9.75% | 23.71B | |
-34.52% | 3.23B | |
+12.64% | 1.79B | |
+0.27% | 1.67B | |
+36.05% | 1.38B | |
-3.60% | 1.11B | |
-20.26% | 915M | |
-4.34% | 738M | |
-14.00% | 716M |